BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2004
View Archived Issues
Savient updates recent developments
Read More
Antisense morpholino-oligomers inhibit coronavirus proliferation and growth
Read More
Improved prevention of CINV found with a palonosetron combination therapy
Read More
Data on the pharmacokinetics of ramelteon presented at sleep conference
Read More
Neurogen provides update on portfolio of clinical and preclinical programs
Read More
PSMA-targeting immunotherapies presented at ASCO
Read More
Vical provides program update
Read More
Novel inotropic agent shows more potency than ouabain
Read More
Promising nonprostanoid prostacyclin receptor agonist for the treatment of chronic vascular disease
Read More
Targeting of Nurr1 gene promising for Parkinson's disease therapy
Read More
Trinam receives orphan medicinal product status in Europe
Read More
FDA sets action date for Metvix review
Read More
Copaxone PFS available in Europe
Read More
Additionional analysis of phase III U.S. trial for the Intercept Blood System
Read More
Actelion and Celltech modify Zavesca license agreement
Read More
Fast track designation for BAL-5788 in hospital-acquired pneumonia
Read More
ILX-651 in new phase II trial for hormone-refractory prostate cancer
Read More
Full enrollment in phase III Virulizin trial
Read More
New phase II trial studies talabostat for advanced metastatic melanoma
Read More
Results from confirmatory phase II study of Aquavan
Read More
Levitra enters Japanese market
Read More
Novel inhibitors of Src kinases developed at Roche
Read More
Guilford patent covers new DPPIV inhibitors and their therapeutic use
Read More
New bone or tissue-selective SARMs under study at Merck
Read More
Merck scientists develop new NO-releasing COX-2 inhibitors
Read More
Merck researchers describe new protein kinase inhibitors and their use
Read More
New TNF-alpha production inhibitors prepared and tested by Ajinomoto team
Read More
Dual PPARalpha/PPARgamma agonists presented by Roche researchers
Read More